Pharma News & Analysis

Sunday, December 5, 2010

Alzheimer's - Funny


at 11:26:00 PM
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Newer Post Older Post Home

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments

Popular Posts

  • Funny Clinical Research Cartoons
  • MenAfriVac, meningitis vaccine administered to 100 millionth person
  • Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis
  • Access to Medicine Index 2012
  • Chimerix Presents Data Highlighting Burden Of Care Associated With Current Antiviral Therapies In Stem Cell Transplantation
  • Colleges offering Pharm.D in Andhra Pradesh
  • FDA agrees to review Merck's Suvorexant for sleeplessness
  • New drug approved by US FDA for the treatment of COPD
  • Computer Exercises May Offer New Hope for Alzheimer's Patients
  • Merck Opens New Manufacturing Facility in Hangzhou, China

Blog Archive

  • ►  2024 (1)
    • ►  March (1)
  • ►  2023 (16)
    • ►  November (2)
    • ►  October (7)
    • ►  May (7)
  • ►  2022 (13)
    • ►  September (8)
    • ►  July (3)
    • ►  June (1)
    • ►  April (1)
  • ►  2021 (24)
    • ►  November (13)
    • ►  October (8)
    • ►  September (3)
  • ►  2015 (1)
    • ►  April (1)
  • ►  2014 (4)
    • ►  January (4)
  • ►  2013 (44)
    • ►  December (20)
    • ►  November (10)
    • ►  October (2)
    • ►  September (1)
    • ►  May (3)
    • ►  April (8)
  • ►  2012 (343)
    • ►  December (2)
    • ►  November (5)
    • ►  September (112)
    • ►  August (197)
    • ►  July (5)
    • ►  April (4)
    • ►  March (10)
    • ►  February (3)
    • ►  January (5)
  • ►  2011 (121)
    • ►  December (19)
    • ►  October (9)
    • ►  September (11)
    • ►  August (30)
    • ►  June (9)
    • ►  May (8)
    • ►  April (14)
    • ►  March (11)
    • ►  February (6)
    • ►  January (4)
  • ▼  2010 (105)
    • ▼  December (31)
      • 6 MONTH PART-TIME DIPLOMA IN PHARMA REGULATORY AFF...
      • One day Seminar on PATENT STRATEGIES FOR PROTECTIN...
      • Two day Seminar on the Indian Patent Act
      • DBT plans to broadbase SBIRI for benefit of more p...
      • Mumbai wholesalers may suspend purchase of drugs f...
      • Guidance for submission of Biological Application ...
      • Christopher Viehbacher Becomes New PhRMA Board Cha...
      • Ayush hospitals in Tamil Nadu running out of medic...
      • Indian Pharmaceutical Congress (IPC) 2011
      • Patients recommended to continue the use of recomb...
      • Upcoming FDA Advisory Committee Meetings
      • Doctors and pharmacists in Hungary to be encourage...
      • Two-Day Workshop on Practical GCP for Successful B...
      • 62nd Indian Pharmaceutical Congress (IPC) Manipal,...
      • IPC Pharma Expo 2010 kicks off at Manipal with pla...
      • Expert inspection panel on clinical trial on Bhopa...
      • DCGI to introduce 'Preliminary Scrutiny' for appro...
      • Avastin may no longer be used for the treatment of...
      • 21 M Pharm students selected for this year’s ‘TNPS...
      • China and India set to become World leaders for in...
      • Association for the Assessment and Accreditation o...
      • 6 MONTH PART-TIME DIPLOMA IN PHARMA REGULATORY AFF...
      • Get emails on banned drugs.
      • Highlight of Indian Pharmacopoeia 2010
      • GVK Biosciences receives AAALAC Accreditation
      • Jobs in Pharma and Biotech companies
      • Funny Clinical Research Cartoons
      • Alzheimer's - Funny
      • PHARMaceutical EXPO 2010
      • Bioph -India 2010 -Bio Solutions for Pharma
      • One day Seminar on Bioequivalence
    • ►  November (10)
    • ►  August (1)
    • ►  June (7)
    • ►  April (9)
    • ►  March (4)
    • ►  February (24)
    • ►  January (19)
  • ►  2009 (222)
    • ►  December (23)
    • ►  November (6)
    • ►  October (9)
    • ►  September (16)
    • ►  August (62)
    • ►  July (32)
    • ►  June (31)
    • ►  May (17)
    • ►  March (15)
    • ►  February (11)
  • ►  2008 (29)
    • ►  December (4)
    • ►  September (1)
    • ►  July (2)
    • ►  June (6)
    • ►  May (1)
    • ►  April (5)
    • ►  March (7)
    • ►  January (3)
  • ►  2007 (3)
    • ►  December (2)
    • ►  October (1)

Topics

pharma (171) regulation (82) drugs (81) Regulatory (63) News (57) Education (55) clinical (51) clinical research (49) FDA (45) clinical trials (40) conference (29) swine flu (28) DCGI (27) Approval (25) India (25) workshop (25) markets (23) admission (19) colleges (19) company news (19) patent (19) seminar (19) job (18) research (18) vacancy (15) courses (14) IPR (11) pharm.d (11) pharmacy (11) New drugs (10) vaccines (10) IPC (9) M.Pharm (9) statistics (9) training (9) CRO (8) WHO (8) cancer (8) diseases (8) government (8) Pharmacopoeia (7) oncology (7) Awards (6) NIPER (6) Pfizer (6) expo (6) healthcare (6) people (6) sales (6) BMS (5) FDC (5) GSK (5) Industry (5) NPPA (5) PCI (5) diabetes (5) exports (5) guidance (5) spurious drugs (5) DTAB (4) DoP (4) ban (4) biotech (4) career (4) certification (4) diagnostics (4) journals (4) pharmacovigilance (4) teaching (4) CDSCO (3) Devices (3) FICCI (3) GATE (3) ICMR (3) IDMA (3) Malaria (3) Novartis (3) Roche (3) articles (3) banned drugs (3) blog (3) generics (3) interview (3) job cuts (3) law (3) market research (3) policy (3) recruitment (3) technology (3) virtual clinical trials (3) AICTE (2) AIDS (2) AIIMS (2) AstraZeneca (2) Ayush (2) BCG (2) Biocon (2) CDA (2) China (2) DLBCL (2) Deal (2) Discovery (2) EMEA (2) Europe (2) GMP (2) HIV (2) Hospital (2) IMS (2) IND (2) IPA (2) Maharastra (2) Manufacturing (2) Merck (2) Ranbaxy (2) SRF (2) Sanofi (2) Strategy (2) Weight loss (2) abstacts (2) adverticle (2) biosimilars (2) chikungunya (2) counselling (2) fraud (2) funny (2) machinery (2) manipal (2) marketing (2) meeting (2) merger (2) pharmacology (2) pricing (2) project (2) side effects (2) tamilnadu (2) testing (2) treatment (2) videos (2) ACTE (1) AIPS (1) ASBMR (1) Access to Medicine (1) Africa (1) Amylin (1) Ardea (1) Arthritis (1) Atropa (1) Awareness (1) BA/BE (1) BITS Pilani (1) British (1) CBER (1) CCMB (1) CCRH (1) CEP (1) CFDA (1) CHMP (1) CII (1) COPD (1) CPHl (1) Chronic Diseases (1) ClinicalTrials.gov (1) Colchicine (1) Crowdsourcing (1) DBT (1) DCA (1) DPCO (1) DPST (1) DST (1) Dapagliflozin (1) Diabetic retinopathy (1) Diptheria (1) Drug discontinuation (1) Drug inspector (1) Elder (1) Electroceuticals (1) Events (1) FDCA (1) FGSCDA (1) FMRAI (1) Febuxostat (1) Formulary (1) GDP (1) GOBIOM (1) GPAT (1) GVK (1) Gene (1) Gout (1) H1N1 (1) HPV (1) Heart failure (1) Hepatitis (1) ICT (1) ILDS (1) IPGA (1) IPSCON (1) IRB (1) ISCR (1) Import (1) Infants (1) Influenza (1) Innocentive (1) Insomnia (1) Internet (1) Investment (1) JOVE (1) JRF (1) JnJ (1) KDPMA (1) Launch (1) Lilly (1) MBA (1) MCI (1) MHRA (1) MedImmune (1) Media (1) Medical (1) Medical Tourism (1) Medicine (1) Medicines (1) Meningitis (1) Monographs (1) Mutation (1) NDA (1) Nanomedicine (1) Neuroscience (1) OAB (1) Obesity (1) Operations (1) Osteoarthritis (1) Ozone Pharma (1) Pharma Industry (1) Pharmexcil (1) Phase IV (1) Pipeline (1) Pneumonia (1) Preclinical (1) QA (1) QIP (1) Reference (1) SMS (1) Smoking (1) Standards (1) Sun Pharma (1) TB (1) TNCDA (1) Takeda (1) Teijin (1) Tetanus (1) Thyroid (1) Tobacco (1) UGC (1) UK (1) URL pharma (1) US (1) Wyeth (1) accredition (1) adverse effects (1) albinism (1) alternative medicine (1) amgen (1) bihar (1) bill (1) biomarker (1) biopharm (1) brain fever (1) budget (1) campaign (1) cisapride (1) contest (1) counterfeit (1) court (1) cpcsea (1) cytrx (1) degree (1) delhi (1) depression (1) device (1) diet (1) draft (1) drugs control (1) economy (1) ethics (1) exam (1) faculty (1) grants (1) hyderabad (1) info (1) informed consent (1) innovation (1) inspection (1) international (1) jobs (1) karnataka (1) kerala (1) lab (1) lesinurad (1) loans (1) misconduct (1) new year (1) nimesulide (1) novo nordisk (1) nuts (1) orchid (1) osteoporosis (1) overpricing (1) parliament (1) peanuts (1) pharmacogenomics (1) phase I (1) pictures (1) pollution (1) product safety (1) profit (1) rajasthan (1) recognition (1) report (1) resistance (1) reward (1) salary (1) scholarships (1) serum institute (1) sibutramine (1) skin cancer (1) soft tissue sarcoma (1) sri lanka (1) stiefel (1) stockists (1) support (1) survey (1) symposia (1) tanzania (1) thanks (1) transplantation (1) updates (1) virus (1) what to name it (1) youtube (1)
Copyright© 2016, Pharma News & Analysis. Powered by Blogger.